ONEBODE - RECOVER
Natural health product licensed in Canada
- Licence holder
- OneBode Holdings, LLC
- NPN or DIN-HM
- 80039145
- Status
- Active licence
- Licence date
- 30 January 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 4-alpha-D-Glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier Potency : 100 FCC DU | 1.71 mg | Not calculated |
| 4-alpha-D-Glucane glucanohydrolase Source : Cells Potency : 100 FCC DU | 1.71 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma reesei - en entier Potency : 3 FCC CU | 0.08 mg | Not calculated |
| 1,4-bêta-D-mannane mannanohydrolase Source : Trichoderma reesei - en entier Potency : 14 FCC HCU | 0.4 mg | Not calculated |
| 4-alpha-D-Glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier Potency : 1,043 FCC DU | 10 mg | Not calculated |
| 4-alpha-D-Glucane glucanohydrolase Source : Cells Potency : 1,043 FCC DU | 10 mg | Not calculated |
| Phyllanthus emblica Source : Pericarp | 1 mg | Not calculated |
| Diastase du malt Source : Aspergillus flavus var. oryzae - En entier Potency : 2 FCC DP | 0.06 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier Potency : 21,450 FCC HUT | 75 mg | Not calculated |
| 3-(O-6-désoxy-alpha-l-mannopyranosyl-(1-6)-bêta-d-glucopyranosyloxy)-2-(3,4-dihydroxyphényl)-5,7-dihydroxy-4H-chromen-4-one Source : Camellia sinensis - feuille | 1 mg | Not calculated |
| Triacylglycérol lipase Source : Aspergillus niger - En entier Potency : 1 FCC LU | 0.13 mg | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige Potency : 5,400,000 FCC PU | 73 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Eau, rouge de betterave, Mélasse
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps in connective tissue formation. Helps in wound healing. An antioxidant for the maintenance of good health. Helps to maintain healthy skin. Helps the body to metabolize carbohydrates, fats and proteins. Helps to maintain immune function. Helps to form red blood cells. Vitamin C helps in the development and maintenance of bones, cartilage, teeth and gums, is an antioxidant for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80039145
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.